Skip to main navigation Skip to search Skip to main content

Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025

  • Laura D. Zambrano
  • , Regina M. Simeone
  • , Margaret M. Newhams
  • , Amanda B. Payne
  • , Natasha B. Halasa
  • , Amber O. Orzel-Lockwood
  • , Jemima M. Calixte
  • , Satoshi Kamidani
  • , Hillary Crandall
  • , Melissa A. Cameron
  • , Jennifer E. Schuster
  • , Aline B. Maddux
  • , Kathleen Chiotos
  • , Katherine Irby
  • , Steven L. Shein
  • , Mary Allen Staat
  • , Lora M. Martin
  • , Samina S. Bhumbra
  • , Ryan A. Nofziger
  • , Jigar C. Chauhan
  • Danielle M. Zerr, Shira J. Gertz, Judith A. Guzman-Cottrill, Michele Kong, Janet R. Hume, Bria M. Coates, Kelly N. Michelson, Emily R. Levy, Tamara T. Bradford, Stephanie P. Schwartz, Tracie C. Walker, Melissa S. Stockwell, Austin Biggs, Alexander H. Hogan, Katherine Lindsey, Angela P. Campbell, Adrienne G. Randolph

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Nirsevimab Effectiveness Against Intensive Care Unit Admission for Respiratory Syncytial Virus in Infants - 24 States, December 2024-April 2025'. Together they form a unique fingerprint.
Sort by

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology